[PDF][PDF] An overview of the history, pathophysiology, and pharmacological interventions of multiple sclerosis

IM Dighriri, AA Aldalbahi, F Albeladi, AA Tahiri… - Cureus, 2023 - cureus.com
Multiple sclerosis (MS) is an immune-inflammatory disease that attacks and damages
myelinated axons in the central nervous system (CNS) and causes nontraumatic …

Inflammation as common link to progressive neurological diseases

A Dias-Carvalho, SI Sá, F Carvalho, E Fernandes… - Archives of …, 2024 - Springer
Life expectancy has increased immensely over the past decades, bringing new challenges
to the health systems as advanced age increases the predisposition for many diseases. One …

Aging and neurodegenerative disease: is the adaptive immune system a friend or foe?

K Mayne, JA White, CE McMurran, FJ Rivera… - Frontiers in aging …, 2020 - frontiersin.org
Neurodegenerative diseases of the central nervous system (CNS) are characterized by
progressive neuronal death and neurological dysfunction, leading to increased disability …

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

L Kular, Y Liu, S Ruhrmann, G Zheleznyakova… - Nature …, 2018 - nature.com
The human leukocyte antigen (HLA) haplotype DRB1* 15: 01 is the major risk factor for
multiple sclerosis (MS). Here, we find that DRB1* 15: 01 is hypomethylated and …

Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity

A Watad, S Azrielant, NL Bragazzi, K Sharif… - Journal of …, 2017 - Elsevier
Autoimmune diseases (ADs) are a heterogeneous groups of diseases that occur as a results
of loss of tolerance to self antigens. While the etiopathogeneis remain obscure, different …

Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis

MC Graves, M Benton, RA Lea, M Boyle… - Multiple Sclerosis …, 2014 - journals.sagepub.com
Background: Multiple sclerosis (MS) is thought to be caused by T-cell mediated autoimmune
dysfunction. Risk of develo** MS is influenced by environmental and genetic factors …

Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?

JY Broos, RTM van der Burgt, J Konings… - Journal of …, 2024 - Springer
Background Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous
system (CNS), characterized by neuroinflammation, demyelination, and neurodegeneration …

Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression

VRC Aguiar, EC Castelli, RM Single, A Bashirova… - Immunogenetics, 2023 - Springer
Human leukocyte antigen (HLA) class I and II loci are essential elements of innate and
acquired immunity. Their functions include antigen presentation to T cells leading to cellular …

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

S Hässler, D Bachelet, J Duhaze, N Szely… - PLoS …, 2020 - journals.plos.org
Background Biopharmaceutical products (BPs) are widely used to treat autoimmune
diseases, but immunogenicity limits their efficacy for an important proportion of patients. Our …

Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study

G Butler-Laporte, D Kreuzer, T Nakanishi… - Open forum …, 2020 - academic.oup.com
Background Infectious diseases are causally related to a large array of noncommunicable
diseases (NCDs). Identifying genetic determinants of infections and antibody-mediated …